Market Closed -
Nasdaq Stockholm
12:00:00 2024-07-05 pm EDT
|
5-day change
|
1st Jan Change
|
45.75
SEK
|
+1.33%
|
|
+4.45%
|
+26.73%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,679
|
7,141
|
6,195
|
3,898
|
5,810
|
7,194
|
-
|
-
|
Enterprise Value (EV)
1 |
20,510
|
19,401
|
19,559
|
18,196
|
19,636
|
22,761
|
22,508
|
21,140
|
P/E ratio
|
106
x
|
-7.88
x
|
110
x
|
-86.5
x
|
15.5
x
|
16.7
x
|
12
x
|
10.1
x
|
Yield
|
-
|
-
|
-
|
-
|
2.77%
|
2.61%
|
3.19%
|
3.39%
|
Capitalization / Revenue
|
0.73
x
|
0.58
x
|
0.48
x
|
0.27
x
|
0.34
x
|
0.38
x
|
0.36
x
|
0.34
x
|
EV / Revenue
|
1.72
x
|
1.58
x
|
1.52
x
|
1.26
x
|
1.14
x
|
1.21
x
|
1.13
x
|
1.01
x
|
EV / EBITDA
|
10.6
x
|
9.45
x
|
9.03
x
|
8.37
x
|
6.45
x
|
6.77
x
|
6.19
x
|
5.7
x
|
EV / FCF
|
23.3
x
|
10
x
|
16.2
x
|
10.1
x
|
-
|
16.9
x
|
9.39
x
|
8.54
x
|
FCF Yield
|
4.3%
|
9.96%
|
6.18%
|
9.93%
|
-
|
5.9%
|
10.6%
|
11.7%
|
Price to Book
|
1.49
x
|
1.47
x
|
1.26
x
|
0.78
x
|
1.08
x
|
1.24
x
|
1.16
x
|
1.02
x
|
Nbr of stocks (in thousands)
|
160,879
|
160,913
|
160,913
|
160,933
|
160,933
|
157,241
|
-
|
-
|
Reference price
2 |
53.95
|
44.38
|
38.50
|
24.22
|
36.10
|
45.75
|
45.75
|
45.75
|
Announcement Date
|
2/13/20
|
2/10/21
|
2/10/22
|
2/10/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
11,935
|
12,288
|
12,867
|
14,496
|
17,287
|
18,859
|
19,999
|
20,922
|
EBITDA
1 |
1,940
|
2,053
|
2,166
|
2,174
|
3,045
|
3,363
|
3,635
|
3,711
|
EBIT
1 |
672
|
673
|
755
|
616
|
1,274
|
1,404
|
1,602
|
1,729
|
Operating Margin
|
5.63%
|
5.48%
|
5.87%
|
4.25%
|
7.37%
|
7.45%
|
8.01%
|
8.26%
|
Earnings before Tax (EBT)
1 |
107
|
-926
|
103
|
-42
|
478
|
554.9
|
769.4
|
916.8
|
Net income
1 |
81
|
-904
|
56
|
-45
|
376
|
433.1
|
600.2
|
715.1
|
Net margin
|
0.68%
|
-7.36%
|
0.44%
|
-0.31%
|
2.18%
|
2.3%
|
3%
|
3.42%
|
EPS
2 |
0.5100
|
-5.630
|
0.3500
|
-0.2800
|
2.330
|
2.745
|
3.827
|
4.526
|
Free Cash Flow
1 |
882
|
1,932
|
1,208
|
1,806
|
-
|
1,344
|
2,397
|
2,475
|
FCF margin
|
7.39%
|
15.72%
|
9.39%
|
12.46%
|
-
|
7.13%
|
11.99%
|
11.83%
|
FCF Conversion (EBITDA)
|
45.46%
|
94.11%
|
55.77%
|
83.07%
|
-
|
39.97%
|
65.94%
|
66.69%
|
FCF Conversion (Net income)
|
1,088.89%
|
-
|
2,157.14%
|
-
|
-
|
310.31%
|
399.39%
|
346.1%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
1.000
|
1.195
|
1.460
|
1.550
|
Announcement Date
|
2/13/20
|
2/10/21
|
2/10/22
|
2/10/23
|
2/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
3,338
|
3,482
|
3,546
|
3,679
|
3,789
|
4,044
|
-
|
4,767
|
4,755
|
4,894
|
EBITDA
1 |
511
|
507
|
481
|
673
|
513
|
-
|
-
|
763
|
998
|
808
|
EBIT
1 |
159
|
127
|
91
|
281
|
117
|
226
|
-
|
267
|
506
|
330
|
Operating Margin
|
4.76%
|
3.65%
|
2.57%
|
7.64%
|
3.09%
|
5.59%
|
-
|
5.6%
|
10.64%
|
6.74%
|
Earnings before Tax (EBT)
1 |
-
|
-42
|
-68
|
121
|
-53
|
36
|
-
|
58
|
291
|
118
|
Net income
1 |
-9
|
-33
|
-63
|
95
|
-44
|
28
|
63
|
45
|
227
|
92
|
Net margin
|
-0.27%
|
-0.95%
|
-1.78%
|
2.58%
|
-1.16%
|
0.69%
|
-
|
0.94%
|
4.77%
|
1.88%
|
EPS
2 |
-
|
-
|
-
|
-
|
-
|
-
|
0.3900
|
0.2800
|
1.430
|
0.5800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/22
|
5/6/22
|
7/21/22
|
10/26/22
|
2/10/23
|
4/26/23
|
4/24/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
11,831
|
12,260
|
13,364
|
14,298
|
13,826
|
15,568
|
15,314
|
13,946
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.098
x
|
5.972
x
|
6.17
x
|
6.577
x
|
4.541
x
|
4.629
x
|
4.213
x
|
3.758
x
|
Free Cash Flow
1 |
882
|
1,932
|
1,208
|
1,806
|
-
|
1,344
|
2,397
|
2,475
|
ROE (net income / shareholders' equity)
|
1.39%
|
-17%
|
4.87%
|
-0.91%
|
7.26%
|
7.77%
|
10%
|
10.4%
|
ROA (Net income/ Total Assets)
|
0.39%
|
-4.49%
|
-
|
-0.21%
|
1.66%
|
-
|
-
|
-
|
Assets
1 |
20,748
|
20,126
|
-
|
21,700
|
22,608
|
-
|
-
|
-
|
Book Value Per Share
2 |
36.20
|
30.10
|
30.70
|
31.10
|
33.30
|
37.00
|
39.60
|
44.90
|
Cash Flow per Share
|
7.630
|
14.10
|
8.560
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
345
|
345
|
142
|
187
|
133
|
189
|
200
|
208
|
Capex / Sales
|
2.89%
|
2.81%
|
1.1%
|
1.29%
|
0.77%
|
1%
|
1%
|
0.99%
|
Announcement Date
|
2/13/20
|
2/10/21
|
2/10/22
|
2/10/23
|
2/8/24
|
-
|
-
|
-
|
Last Close Price
45.75
SEK Average target price
57.5
SEK Spread / Average Target +25.68% Consensus |
1st Jan change
|
Capi.
|
---|
| +26.73% | 686M | | +18.33% | 83.89B | | -28.29% | 71.08B | | +1.34% | 26.86B | | +3.67% | 17.74B | | -9.99% | 17.24B | | +1.86% | 15.6B | | +79.98% | 13.84B | | -25.44% | 12.92B | | +74.41% | 12.87B |
Other Healthcare Facilities & Services
|